TLR2 and myelodysplastic syndrome: [46], searching for potential biomarkers in MDS patients, noticed increased levels of TLR2 and TLR4 mRNA in the bone marrow of MDS patients in comparison to healthy controls, possibly relating to an increased expression of these genes in individuals with the disease, demonstrated in Table 1.